Clinical Trials Logo

Parkinson's clinical trials

View clinical trials related to Parkinson's.

Filter by:

NCT ID: NCT06036433 Recruiting - Disease Clinical Trials

Light Therapy Plus Exercise to Improve Motor, Non-Motor Symptoms and QoL in Parkinson's Disease

Start date: January 2, 2023
Phase: N/A
Study type: Interventional

Parkinson's disease (PD) is a lifelong and progressive disease and is the second most common progressive neurodegenerative disease worldwide. This study will examine whether there are significant differences in motor (e.g., balance and gait) and non-motor (e.g., cognition, mood, smell & sleep ) symptoms and quality of life between the Real (active) at-home photobiomodulation (light therapy) combined with exercise group and the Placebo (sham) at-home photobiomodulation (light therapy) combined with exercise group. Each group (Real & Placebo) will include 30 participants; with moderate PD, ages 55-80. Three outcome measurement sessions will be conducted; at the study entry and the end of Weeks 1 & 4 after the last light therapy treatment. Exercise must have been part of the participant's routine before entering the study and will continue during and after the light therapy treatments have been completed.

NCT ID: NCT05518617 Recruiting - Parkinson Disease Clinical Trials

Molecular and Functional Imaging in Monogenic PD.

FOX_1
Start date: July 1, 2022
Phase:
Study type: Observational

In this study, the investigators aim to find a biomarker of Parkinson's disease. This is done using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The findings will provide a deeper understanding of the brain changes in Parkinson's disease. More importantly, this study will help with the discovery and development of new medications aiming to delay progression of PD symptoms.

NCT ID: NCT05516732 Recruiting - Parkinson Disease Clinical Trials

Serotonin Release in Premotor and Motor PD

FOX3
Start date: July 1, 2022
Phase:
Study type: Observational

In this study, the investigators aim to provide a deeper understanding of Parkinson's disease and find a biomarker of Parkinson's disease. This is done using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The findings will provide a deeper understanding of the brain changes in Parkinson's disease. More importantly, this study will help with the discovery and development of new medications aiming to delay progression of Parkinson's disease symptoms

NCT ID: NCT05516719 Recruiting - Parkinson Disease Clinical Trials

Longitudinal Investigation of I2BS in PD

FOX_2
Start date: November 1, 2021
Phase:
Study type: Observational

In this study, the researchers aim to find a biomarker of PD. Using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The PET and SPECT scans use small amounts of radiation and specific compounds called tracers, to study chemical changes in the brain in a way not possible with any other procedure. The MRI uses magnetic fields to generate images of brain structure and function

NCT ID: NCT02670161 Enrolling by invitation - Stroke Clinical Trials

Quality Improvement and Practice Based Research in Neurology Using the EMR

Start date: May 2016
Phase: Phase 4
Study type: Interventional

The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.

NCT ID: NCT02561715 Withdrawn - Parkinson's Clinical Trials

Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson's

Start date: August 1, 2015
Phase:
Study type: Observational

Anosognosia is a recognised condition for people with Parkinson's, and is the result of physiological damage on brain structure. Surgical Parkinson Disease Nurse Specialists have noticed that when reviewing the pre-surgery videos 12 months post-DBS, patients have forgotten and are shocked at how bad their symptoms were prior to surgery (personal communication), which may not be reflected in the change in QoL reported. This lack of awareness, while possibly helpful in everyday life, may lead to effective treatments looking ineffective, or the benefits in QoL of effective treatment appearing reduced. This confound may not only reduce the apparent effectiveness but also the related cost-effectiveness of treatment. As cost-effectiveness is determined by both size and longevity of an effect, current methods of capturing these data may be suboptimal.

NCT ID: NCT02468804 Completed - Parkinson's Clinical Trials

Cognitive Dysfunction In Parkinson's

KL2
Start date: August 2013
Phase: N/A
Study type: Interventional

We hypothesize that reductions in gamma activity are a key mechanism underlying cognitive dysfunction in PD and that interventions to increase gamma activity will improve cognition.

NCT ID: NCT02315781 Terminated - Depression Clinical Trials

tDCS in Parkinson's Disease With Depression

Start date: January 2015
Phase: N/A
Study type: Interventional

Parkinson's disease (PD) is a progressive neurological disease that has effects on both movement and mental health. One of the most common mental health complications of PD is depression. Up to 30% of Parkinson's patients will experience depression at some point. We aim to investigate whether transcranial direct current stimulation (tDCS), a type of electrical stimulation for the brain, can improve depression in PD as well as improve motor function in PD.

NCT ID: NCT02271685 Completed - Alzheimer Disease Clinical Trials

Sound Estimation and Accuracy Task

Start date: February 2015
Phase: N/A
Study type: Interventional

Participants will be assigned to complete computerized estimation tasks for which there is a component of accuracy, such as estimating the duration of sounds. Participants will be told that the task is used as an early diagnostic tool to detect those at risk for a medical condition (e.g., Parkinson's disease, Alzheimer's disease). Instructions will be given to participants telling them that accuracy on the task is associated with the disease, whereas those who are not at risk of the disease tend to either overestimate or underestimate the duration of the sounds. The investigators examine whether such instructions about the purpose and diagnosticity of the tasks biases participants' responses to the tasks, leading them to purposefully be more inaccurate in their estimates.

NCT ID: NCT02177149 Withdrawn - Parkinson's Clinical Trials

Nurse Management of Neuromodulation Therapy

DBS
Start date: February 2014
Phase: N/A
Study type: Interventional

The central hypothesis is that the use of a DBS (Deep Brain Stimulation) clinical decision support system for individual patient management will enable considerable time savings compared to standard care. This hypothesis was formulated from pilot studies that showed dramatic decreases in DBS programming time compared to standard care for clinicians who used an iPad-based decision support system (99% time savings from over 4 hours to 2 minutes. Study group Parkinson's patients with DBS Systems